Friday, July 10, 2026

biotech · Autoimmune Diseases

Connect Biopharm

Connect Biopharm is a biotech organization headquartered in CN. Primary therapeutic focus areas include Autoimmune Diseases. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this e

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
0
Patents
0
Clinical program

CBP-307

Phase 1 · small molecule · Autoimmune Diseases

CBP-307 for Autoimmune Diseases is a Phase 1 program (small_molecule) at Connect Biopharm with 1 ClinicalTrials.gov record(s).

← All Connect Biopharm projects Phase 1 small molecule completed

Internal code CBP-307AU001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Connect Biopharm
Phase
Phase 1
Modality
small_molecule
Indication
Autoimmune Diseases
Status
completed
Trials
1

Clinical trials